Alternative Clinical Indications of Botulinum Toxin

Area of Science:

• Dermatology
• Neurotoxins
• Medical Aesthetics

Background:

• Botulinum toxin type A (BoNTA) is a neurotoxin that inhibits acetylcholine release.
• Its safety and efficacy profile support its broad therapeutic applications.
• BoNTA is frequently used off-label for numerous dermatologic conditions.

Purpose of the Study:

• To review the published literature on the off-label applications of BoNTA in dermatology.
• To analyze the benefits and risks associated with using BoNTA for conditions beyond facial lines.
• To consolidate current evidence on BoNTA's efficacy in treating specific dermatologic concerns.

Main Methods:

• A comprehensive literature search was performed using MEDLINE.
• The search covered the period from January 2000 to December 2019.
• Studies focusing on off-label dermatologic uses of botulinum toxin were included.

Main Results:

• The review encompasses off-label uses of BoNTA for conditions including eccrine hidrocystomas, enlarged pores, keloids, hypertrophic scars, hidradenitis suppurativa, hyperhidrosis, masseter muscle hypertrophy, and salivary gland hypertrophy.
• Evidence regarding the benefits and risks for these specific conditions was analyzed.
• The literature indicates a growing range of therapeutic applications for BoNTA in dermatology.

Conclusions:

• Botulinum toxin type A demonstrates considerable potential for treating a diverse array of dermatologic conditions beyond cosmetic facial lines.
• Further research and clinical data are essential to fully elucidate the risk-benefit profile for each off-label indication.
• BoNTA represents a valuable therapeutic option in medical dermatology for various non-cosmetic applications.